Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT08 for Helicobacter pylori Infection
NCT01109381Phase 2Terminated
- Sponsor
- Synergy Pharmaceuticals Inc.
- Start
- May 2010
- Primary completion
- Dec 2011
- Modality
- Drug Delivery Systems, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lauric acid in Helicobacter pylori infection, sponsored by Synergy Pharmaceuticals Inc.. Started May 2010; status: terminated.
02
Drugs
lauric acid
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01109381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01109381.